https://www.selleckchem.com/pr....oducts/Idarubicin.ht
The uniqueness of this observation lies in the fact that a patient 6 years after heart transplantation was diagnosed with laryngeal cancer, he underwent combined treatment with neoadjuvant radiation therapy, TFD 44 Gy and an operation in the volume of laryngectomy without complications. The optimal indicators and adequate criteria for the quantitative assessment of hearing loss excess risk with noise exposure above 80 dBA is urgently needed determination. The technology for calculating hearing thresholds according to the model of the
Like
Comment
Share
